{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:32:54Z","timestamp":1764174774503,"version":"3.41.2"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00067","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:21:18Z","timestamp":1581034878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Ocular Side Effects of Sildenafil That Persist Beyond 24 h\u2014A Case Series"],"prefix":"10.3389","volume":"11","author":[{"given":"C\u00fcneyt","family":"Karaarslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"B1","first-page":"47","article-title":"Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int J Impot Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0022-5347(01)63100-8","article-title":"Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro","volume":"160","author":"Chuang","year":"1998","journal-title":"J Urol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDE and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2001.163","article-title":"Effect of sildenafil on ocular hemodynamics","volume":"15","author":"D\u00fcndar","year":"2001","journal-title":"Eye"},{"key":"B5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/sj.ijir.3901416","article-title":"Effect of sildenafil on ocular hemodynamics in 3 months regular use","volume":"8","author":"D\u00fcndar","year":"2006","journal-title":"Int J Impot Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.2147\/DDDT.S118015","article-title":"Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction","volume":"8","author":"Moschos","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1350-9462(02)00013-7","article-title":"Viagra\u00ae (sildenafil citrate) and opthalmology","volume":"21","author":"Laties","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jamaophthalmol.2018.4716","article-title":"Association of transient color blindness with sildenafil and tadalafil","volume":"137","author":"Rosen","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ijir.2008.25","article-title":"Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction","volume":"20","author":"Thurtell","year":"2008","journal-title":"Int J Impot Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/WNO.0000000000000186","article-title":"Association between phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy","volume":"35","author":"Nathoo","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1167\/iovs.18-26333","article-title":"Effects of sildenafil in na\u00efve mice and a mouse model of optic nerve crush","volume":"60","author":"Zahavi","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:21:20Z","timestamp":1581034880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":11,"alternative-id":["10.3389\/fneur.2020.00067"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00067","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"article-number":"67"}}